Related references
Note: Only part of the references are listed.A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker
Alessandra Santangelo et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells
Ming Sun et al.
BIOLOGICAL CHEMISTRY (2018)
LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
Yanxia Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma
Simin Li et al.
ORAL ONCOLOGY (2017)
RNA in extracellular vesicles
Kyoung Mi Kim et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
IncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-kB/TS Signaling in Colorectal Cancer
Peilong Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
PART-1 functions as a competitive endogenous RNA for promoting tumor progression by sponging miR-143 in colorectal cancer
Yongbo Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Systematic Analysis of Long Noncoding RNAs in the Senescence-accelerated Mouse Prone 8 Brain Using RNA Sequencing
Shuai Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
K. Sugimachi et al.
BRITISH JOURNAL OF CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity
Evangelos Pefanis et al.
CELL (2015)
Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
Meng Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
Niels F. Jensen et al.
MOLECULAR ONCOLOGY (2015)
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Stephanie Boukouris et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
Pedram Kharaziha et al.
ONCOTARGET (2015)
IncRNA recruits RNAi and the exosome to dynamically regulate pho1 expression in response to phosphate levels in fission yeast
Sneha Shah et al.
GENES & DEVELOPMENT (2014)
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
Karmele Valencia et al.
MOLECULAR ONCOLOGY (2014)
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
Lesley Cheng et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
Hiroaki Kato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Noncoding RNA and Polycomb recruitment
Neil Brockdorff
RNA (2013)
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
M. Karaayvaz et al.
CELL DEATH & DISEASE (2013)
The role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cells
Shangwen Dong et al.
ONCOLOGY LETTERS (2013)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
Intercellular Nanovesicle-Mediated microRNA Transfer: A Mechanism of Environmental Modulation of Hepatocellular Cancer Cell Growth
Takayuki Kogure et al.
HEPATOLOGY (2011)
Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression
Kristin Gurtner et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'
Tae Hoon Lee et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know
Mizuki Nishino et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I)
Katsuhiro Masago et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma - Tissue effect predicts clinical response
Milind Javle et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
A phase II study of gefitinib monotherapy in advanced Esophageal adenocarcinoma: Evidence of gene expression, cellular, and clinical response
David R. Ferry et al.
CLINICAL CANCER RESEARCH (2007)
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib
David M. Jackman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo
F Hara et al.
CANCER LETTERS (2005)
The EGF receptor family as targets for cancer therapy
J Mendelsohn et al.
ONCOGENE (2000)
Share Paper
